Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Slamon, D.J.
530  Ergebnisse:
Personensuche X
?
1

Updated overall survival from the MONALEESA-3 trial in post..:

Neven, P. ; Fasching, P. A. ; Chia, S....
Breast Cancer Research.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
2

Results of TRIO-15, a multicenter, open-label, phase II stu..:

Davidson, T.M. ; Lebreton, C.L. ; Hendricksen, A.E. Wahner...
Gynecologic Oncology.  170 (2023)  - p. 221-228 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Pooled ctDNA analysis of MONALEESA phase III advanced breas..:

André, F. ; Su, F. ; Solovieff, N....
Annals of Oncology.  34 (2023)  11 - p. 1003-1014 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Corrigendum to "Tucatinib versus placebo added to trastuzum..:

Curigliano, G. ; Mueller, V. ; Borges, V....
Annals of Oncology.  34 (2023)  7 - p. 630 , 2023
Link: https://doi.org/10.1016/..
 
?
5

MA07.05 Phase 1b/2 Study of Combined HER Inhibition in Refr..:

Goldman, J. ; Huang, H.K.T. ; Cummings, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S68-S69 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Tucatinib versus placebo added to trastuzumab and capecitab..:

Curigliano, G. ; Mueller, V. ; Borges, V....
Annals of Oncology.  33 (2022)  3 - p. 321-329 , 2022
Link: https://doi.org/10.1016/..
 
?
7

OA12.03 Phase 2 Study Analysis of Talazoparib (TALA) Plus T..:

Goldman, J. ; Cummings, A. ; Mendenhall, M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S32 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Ribociclib plus fulvestrant for postmenopausal women with h..:

Slamon, D.J. ; Neven, P. ; Chia, S....
Annals of Oncology.  32 (2021)  8 - p. 1015-1024 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Results of TRIO-14, a phase II, multicenter, randomized, pl..:

Konecny, G.E. ; Hendrickson, A.E. Wahner ; Davidson, T.M....
Gynecologic Oncology.  163 (2021)  3 - p. 465-472 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Corrigendum to 'Ribociclib plus fulvestrant for postmenopau..:

Slamon, D.J. ; Neven, P. ; Chia, S....
Annals of Oncology.  32 (2021)  10 - p. 1307 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Palbociclib plus letrozole as first-line therapy in estroge..:

Rugo, H. S. ; Finn, R. S. ; Diéras, V....
Breast Cancer Research and Treatment.  174 (2019)  3 - p. 719-729 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Impact of palbociclib plus letrozole on patient-reported he..:

Rugo, H.S. ; Diéras, V. ; Gelmon, K.A....
Annals of Oncology.  29 (2018)  4 - p. 888-894 , 2018
Link: https://doi.org/10.1093/..
 
?
13

PG 5.01 Targeting CDK 4–6 pathway:

Finn, R.S. ; Slamon, D.J.
The Breast.  24 (2015)  - p. S9 , 2015
Link: https://doi.org/10.1016/..
 
?
14

317 Safety and efficacy results from a phase 1 dose-escalat..:

Wainberg, Z.A. ; Hecht, J.R. ; Konecny, G.E....
European Journal of Cancer.  51 (2015)  - p. S60 , 2015
Link: https://doi.org/10.1016/..
 
?
15

KRAS mutational subtype and copy number predict in vitro re..:

Hamidi, H ; Lu, M ; Chau, K...
British Journal of Cancer.  111 (2014)  9 - p. 1788-1801 , 2014
Link: https://doi.org/10.1038/..
 
1-15